Verifying…
Automatisch übersetzt. Dosierung und Warnhinweise: bitte im englischen Original prüfen. Auf Englisch lesen
Home / Medicines A–Z / Insulin aspart

Insulin aspart

NOVOLOG is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. NOVOLOG is rapid acting human insulin analog.

Checked against the official label · Updated

Prescription medicine Intravenous Safety alerts on record

Insulin aspart: quick answers

What it is
Insulin (diabetes) (Insulin Analog)
Used for
NOVOLOG is indicated to improve glycemic control in.
Children
Prescription
Prescription medicine in the United States; rules differ by country.

From the official label (Dec 2023). Your prescription and pharmacist come first.

How to use Insulin aspart

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Who it is for

NOVOLOG is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. NOVOLOG is rapid acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus ( 1 ).

How to take it and how often
  • See Full Prescribing Information for important preparation, administration, and dosage instructions . • Subcutaneous injection : o Inject subcutaneously within 5-10 minutes before a meal into the abdominal area, thigh, buttocks or upper arm. o Rotate injection sites within the same region from one injection to the next to reduce risk of lipodystrophy and localized cutaneous amyloidosis. o Should generally be used in regimens with an intermediate- or long-acting insulin. • Continuous Subcutaneous Infusion (Insulin Pump) : o Refer to the insulin infusion pump user manual to see if NOVOLOG can be used
  • Use in accordance with the insulin pump instructions for use. o Administer by continuous subcutaneous infusion using an insulin pump in a region recommended in the instructions from the pump manufacturer. o Rotate the injection sites within the same region from one injection to the next to reduce the risk of lipodystrophy and localized cutaneous amyloidosis. o Do not mix with other insulins or diluents in the pump. • Intravenous Administration : o Dilute NOVOLOG to concentrations from 0.05 unit/mL to 1 unit/mL insulin aspart in infusion systems using polypropylene infusion bags. o NOVOLOG is stable in infusion fluids such as 0.9% Sodium Chloride Injection, USP. • Individualize and adjust the dosage of NOVOLOG based on route of administration, the individual's metabolic needs, blood glucose monitoring results and glycemic control goal . …
Strengths it comes in

Injection: 100 units/mL (U-100) is a clear and colorless solution available as: • 10 mL multiple-dose vial • 3 mL single-patient-use PenFill prefilled cartridge for the 3 mL PenFill cartridge delivery device with NovoFine ® disposable needles • 3 mL single-patient-use FlexPen prefilled pen • 3 mL single-patient-use FlexTouch prefilled pen Injection: 100 units/mL (U-100) of insulin aspart available …

Children
  • The safety and effectiveness of NOVOLOG to improve glycemic control have been established
  • In pediatric patients with diabetes mellitus
  • Use of NOVOLOG for this indication is supported by evidence from an adequate and well-controlled study in 283
  • Pediatric patients with type 1 diabetes mellitus aged 6 to 18 years and from studies
  • In adults with diabetes mellitus [see Adverse Reactions , Clinical Pharmacology , and Clinical Studies ]
Older adults

Of the total number of patients (n=1,375) treated with NOVOLOG in 3 controlled clinical studies, 2.6% (n=36) were 65 years of age or over. One-half of these patients had type 1 diabetes (18/1285) and the other half had type 2 diabetes (18/90). The HbA 1c response to NOVOLOG, as compared to regular human insulin, did not differ by age.

While you are taking it
  • Advise the patient to read the FDA-approved patient labeling (Patient Information and Instructions for Use)
  • Never Share a NOVOLOG FlexPen or a NOVOLOG FlexTouch, PenFill Cartridge or PenFill Cartridge Device between Patients Advise patients that they must never share NOVOLOG FlexPen, NOVOLOG FlexTouch, PenFill cartridge or PenFill cartridge devices with another person even if the needle is changed, because doing so carries a risk for transmission of blood-borne pathogens
  • Advise patients using NOVOLOG vials not to share needles or syringes with another person
  • Sharing poses a risk for transmission of blood-borne pathogens [see Warnings and Precautions ] . …
Talk to a doctor first if

NOVOLOG is contraindicated: • During episodes of hypoglycemia [see Warnings and Precautions ( 5.3 )] • In patients with hypersensitivity to NOVOLOG or one of its excipients, [see Warnings and Precautions ( 5.5 )] • During episodes of hypoglycemia ( 4 ). • Hypersensitivity to NOVOLOG or one of its excipients.

Medicines it may not mix with

The table below presents clinically significant drug interactions with NOVOLOG. Drugs That May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analog (e.g., octreotide), and sulfonamide antibiotics. Intervention: Dose adjustment and increased frequency of glucose monitoring may be required when NOVOLOG is concomitantly administered with these drugs. …

Warnings

• Never share a NOVOLOG FlexPen or a NOVOLOG FlexTouch, PenFill cartridge or PenFill cartridge device between patients, even if the needle is changed ( 5.1 ). • Hyperglycemia or hypoglycemia with changes in insulin regimen: Make changes to a patient’s insulin regimen (e.g., insulin strength, manufacturer, type, injection site or method of administration) under close medical supervision with increased frequency of blood glucose monitoring ( 5.2 ). • Hypoglycemia: May be life-threatening. …

Possible side effects

The following adverse reactions are also discussed elsewhere: • Hypoglycemia [see Warnings and Precautions ( 5.3 )] • Hypoglycemia Due to Medication Errors [see Warnings and Precautions (5.4 )] • Hypersensitivity reactions [see Warnings and Precautions ( 5.5 )] • Hypokalemia [see Warnings and Precautions ( 5.6 )] Adverse reactions observed with NOVOLOG include: hypoglycemia, allergic reactions, local injection site reactions, lipodystrophy, rash, and pruritus ( 6 ). To report SUSPECTED ADVERSE REACTIONS, contact Novo Nordisk Inc. at 1-800-727-6500 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. …

Pregnancy and breastfeeding

8.1 Pregnancy Risk Summary Available information from published randomized controlled trials with insulin aspart use during the second trimester of pregnancy have not reported an association with insulin aspart and major birth defects or adverse maternal or fetal outcomes [see Data] . There are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy [see Clinical Considerations] . …

If you take too much

Excess insulin administration may cause hypoglycemia and hypokalemia [see Warnings and Precautions ( 5.3 , 5.6 )] . Mild episodes of hypoglycemia usually can be treated with oral glucose. Adjustments in drug dosage, meal patterns, or exercise may be needed. More severe episodes with coma, seizure, or neurologic impairment may be treated with intramuscular/subcutaneous glucagon or concentrated intravenous glucose. Sustained carbohydrate intake and observation may be necessary because hypoglycemia may recur after apparent clinical recovery. Hypokalemia must be corrected appropriately.

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2023-12-15.

How much Insulin aspart costs

In other countries

Prices in other countries are not what you will pay where you live; they show how prices compare.

What Insulin aspart looks like

Compare with your pack. Packs differ between countries and makers; a pack that looks different is not always fake, so scan it to check the registration.

Brands around the world

Products with Insulin aspart as the active ingredient. Names differ between countries.

Registered products

United States (FDA)

Insulin Aspart-szjjINSULIN ASPART 100 [iU]/mL · Injection, Solution · Sanofi-Aventis Deutschland GmbH
NDC 12854-050Label
FiaspINSULIN ASPART 100 [iU]/mL · Injection, Solution · Novo Nordisk
NDC 0169-3206Label
Insulin Aspart-szjjINSULIN ASPART 100 [iU]/mL · Injection, Solution · Sanofi-Aventis Deutschland GmbH
NDC 12854-060Label
FiaspINSULIN ASPART 100 [iU]/mL · Injection, Solution · Novo Nordisk
NDC 0169-3201Label
FiaspINSULIN ASPART 100 [iU]/mL · Injection, Solution · Novo Nordisk
NDC 0169-3204Label

Nigeria (NAFDAC)

NAFDACRyzodeg FlexTouch 100 U/mL A6-0489NAFDACNovoMix 30 FlexPen 100 U/mL Suspension for Injection in Pre-Filled Pen A6-0204NAFDACNovoRapid FlexPen 100 units/mL Solution for Injection in Pre-Filled Pen A6-0207

Other countries: check your pack's registration number and we point you to your regulator.

Safety alerts and recalls

NovoLog FlexPen (insulin aspart) Injection, 100 units/mL, 3 mL Prefilled Insulin Syringe pen, Sample. Not for Resale, Rx Only, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-633U.S. FDA Class I
22 Mar 2021 · Novo Nordisk Inc · TerminatedTemperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Fiasp PenFill (insulin aspart injection) 100 units/mL (U-100), 3 mL cartridge, 5 cartridges per package, Sample Not for Resale, Rx Only, Manufactured by: Novo Nordisk A/S, BagsvaerU.S. FDA Class I
22 Mar 2021 · Novo Nordisk Inc · TerminatedTemperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Fiasp (insulin aspart injection), 100 units/mL (U-100), One 10 mL multi-dose vial, Sample. Not for Resale, Rx Only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, NDC 0169-U.S. FDA Class I
22 Mar 2021 · Novo Nordisk Inc · TerminatedTemperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Fiasp FlexTouch (insulin aspart injection) 100 units/mL (U-100), 3 mL Prefilled Pen, Sample. Not for Resale, Rx only, Manufactured by: Novo Nordisk, Inc., Bagsvaerd, Denmark, DistrU.S. FDA Class I
22 Mar 2021 · Novo Nordisk Inc · TerminatedTemperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.

A recall usually affects certain batches only. Compare the lot number on your pack.

Check your pack of Insulin aspart

Type the registration number on the pack, or scan it with your camera.

Or take photos of the pack
3 free checks left today Official sources: U.S. FDA · EMA (EU) · Health Canada · WHO alerts

Questions about Insulin aspart

What is Insulin aspart used for?

NOVOLOG is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. NOVOLOG is rapid acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus ( 1 ). (From the official U.S. FDA label.)

How do I take Insulin aspart?

Follow your prescription or the leaflet in your pack. The official label says: See Full Prescribing Information for important preparation, administration, and dosage instructions ( 2.1, 2.2, 2.3, 2.4, 2.5 ). • Subcutaneous injection ( 2.2 ): o Inject subcutaneously within 5-10 minutes before a meal into the abdominal area, thigh, buttocks or upper arm. o Rotate injection sites within the same region from one injection to the next to reduce risk of lipodys…

Is Insulin aspart an antibiotic?

No. Insulin aspart is insulin (diabetes) (official class: Insulin Analog), not an antibiotic. Antibiotics treat bacterial infections only.

Is Insulin aspart a painkiller?

No. Insulin aspart is insulin (diabetes) (official class: Insulin Analog), not a painkiller.

Do I need a prescription for Insulin aspart?

Usually yes. Insulin aspart is a prescription medicine in most countries. Rules differ by country.

What brands contain Insulin aspart?

Insulin aspart is sold under names such as Novolog Mix, Fiasp, Merilog, Kirsty, Garzulys, Novolog. Brand names differ between countries.

What are the side effects of Insulin aspart?

The official label lists: The following adverse reactions are also discussed elsewhere: • Hypoglycemia [see Warnings and Precautions ( 5.3 )] • Hypoglycemia Due to Medication Errors [see Warnings and Precautions (5.4 )] • Hypersensitivity reactions [see Warnings and Precautions ( 5.5 )] • Hypokalemia [see Warnings and Precautions ( 5.6 )] Adverse reactions observed with NOVOLOG include: hypoglycemia, al… Tell your doctor about any side effect that bothers you or does not go away.

Can children take Insulin aspart?

The safety and effectiveness of NOVOLOG to improve glycemic control have been established in pediatric patients with diabetes mellitus. Use of NOVOLOG for this indication is supported by evidence from an adequate and well-controlled study in 283 pediatric patients with type 1 diabetes mellitus aged 6 to 18 years and from studies in adults with diabetes mellitus [see Adverse Rea… Always use the dose for the child's age or weight on the pack or prescription.

Can I take Insulin aspart when pregnant or breastfeeding?

8.1 Pregnancy Risk Summary Available information from published randomized controlled trials with insulin aspart use during the second trimester of pregnancy have not reported an association with insulin aspart and major birth defects or adverse maternal or fetal outcomes [see Data] . There are risks to the mother and fetus associated with poorly controlled diabetes in pregnanc… Ask your doctor or midwife first.

What medicines interact with Insulin aspart?

The table below presents clinically significant drug interactions with NOVOLOG. Drugs That May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analog (e.g., octreotide), and sulfonamide an… Use the free interaction checker before combining medicines.

What happens if I take too much Insulin aspart?

Excess insulin administration may cause hypoglycemia and hypokalemia [see Warnings and Precautions ( 5.3 , 5.6 )] . Mild episodes of hypoglycemia usually can be treated with oral glucose. Adjustments in drug dosage, meal patterns, or exercise may be needed. More severe episodes with coma, seizure, o… Get medical help right away.

How can I check that my Insulin aspart is genuine?

Scan the registration number on your pack with PillVera (NAFDAC number in Nigeria, NDC in the United States, DIN in Canada), check the expiry date and buy only from licensed pharmacies.

Sources

This page shows what official sources say, in plain words. It is not medical advice: your prescription and your doctor or pharmacist come first. Brand names, strengths and rules differ between countries.